EUCOPE News by Tag — Rare Disease

Filtered by Tag: Rare Disease

EUCOPE Resources / Press Releases - January 7, 2021

EUCOPE’s response to the Orphan Medicinal Products and Paediatrics Inception Impact Assessment

EUCOPE, the European association for small to medium-sized companies active in pharmaceuticals and biotechnologies submitted its response to the Paediatric and Orphan Medicinal Products (OMPs) inception impact assessment. EUCOPE represents 130 companies, many focused on rare diseases, largely small to medium-sized, playing a key role… read more

News - December 17, 2020

EMA & HMA Joint Strategy 2021-2025

Published on 8 December, the European Medicines Agency (EMA) and Heads of Medicines Agency (HMA) Joint Strategy looks into six strategic focus areas: (1) Availability and accessibility of medicines, (2) Digital tools and digital transformation, (3) Innovation, (4) Antimicrobial resistance, (5) Supply chain challenges, and… read more

EUCOPE Resources / News / Press Releases - November 25, 2020

EC Pharmaceutical Strategy – Time for a Modern Approach to Value

EUCOPE, the European association for small to medium-sized companies active in pharmaceuticals and biotechnologies – many of which are researching and developing rare disease treatments – notes the publication of the European Commission Communication on the Pharmaceutical Strategy for Europe. EUCOPE calls for a comprehensive Pharmaceutical Strategy… read more

Events & Meetings / News - October 30, 2020

JOIN US: Case studies on rare disease therapies development – A laboratory of ideas for European innovation leadership

Pharmaceutical small to mid-sized companies and start-ups constitute a laboratory of innovation and should be nurtured through a forward-looking European incentives ecosystem that encourages the development of cutting-edge technologies. The upcoming EU health policy initiatives, including the Pharmaceutical Strategy for Europe and the impact assessment… read more

News - October 28, 2020

Sickle Cell Disease: An European Overview

Sickle cell disease is one of the most prevalent genetic diseases in Europe. A recent report, commissioned by our member company Global Blood Therapeutics, use the latest data from 5 EU countries to draw recommendations to improve the life expectancy of people living with this… read more